In this episode of Industry Focus: Wildcard, Jason Moser chats with Motley Fool analyst Brian Feroldi about three promising healthcare stocks that he personally bought.And to your point there, the nice thing about the diagnostic space is, with Semler, they can make the very real argument that spending a little bit of money upfront to screen patients better can lead to enormous cost savings down the road.